GCM
SYNH

Graham Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Graham Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,247
Closed -$766K – 1436
2022
Q3 		$766K Buy
16,247
+12,000
+283% +$775K 0.03% 594
2022
Q2 		$304K Buy
+4,247
New +$310K 0.01% 827

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Graham Capital Management's SYNH Position: Q4 2022 in Review

Graham Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 16,247 shares — an estimated $766K sold.

Graham Capital Management first reported a position in SYNH in Q2 2022 and held it in 2 quarters. The position peaked at $766K in Q3 2022. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • Graham Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Graham Capital Management sold 16,247 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $766K.
  • Graham Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • Graham Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $766K in Q3 2022.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Graham Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.